Fund profile by ISIN IE0006FM6MI8
Amundi ETF ICAV - Amundi S&P World Health Care Screened UCITS ETF Acc
Research Amundi ETF ICAV - Amundi S&P World Health Care Screened UCITS ETF Acc by ISIN IE0006FM6MI8: TER 0.18%, domicile Ireland, accumulating, and 1-year price performance +17.1%.
ISINIE0006FM6MI8
TER0.18%
DomicileIreland
Distribution policyAccumulating
Index—
Fund size995M
Holdings—
1-year price performance+17.1%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| WELS.DE | XETRADefault at German brokers | EUR | Ireland | €279K | 24,425 |
| WEL9.DE | XETRADefault at German brokers | EUR | Ireland | €194K | 14,608 |
| GLHL.PA | XPAR | EUR | Ireland | €22K | 1,879 |
| WEL9.SW | SW | USD | Ireland | €12K | 1,068 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-08-28.
Largest holdings
The 10 largest holdings make up 53.83% of the fund. As of 2026-08-14.
| Holding | Symbol | Weight |
|---|---|---|
| Eli Lilly and Co | LLY | 11.96% |
| AbbVie Inc | ABBV | 8.25% |
| Merck & Co Inc | MRK | 5.09% |
| UnitedHealth Group Inc | UNH | 5.09% |
| Novartis AG Registered Shares | NOVN.SW | 5.06% |
| AstraZeneca PLC | AZN.L | 4.62% |
| Roche Holding AG Ordinary Shares new | ROP.SW | 4.04% |
| Amgen Inc | AMGN | 3.74% |
| Gilead Sciences Inc | GILD | 3.14% |
| Thermo Fisher Scientific Inc | TMO | 2.83% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.